April 8, 2019
Navidea Biopharmaceuticals Receives FDA Feedback Regarding Rheumatoid Arthritis Clinical Trial Design and Provides Business Updates
Company Will Host Conference Call at 5:00 p.m. (ET) on Monday, April 8, 2019 DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE…
